57PA-6 inhibits gain-of-function KIR2.1 channels associated with short QT syndrome type 3 and congenital atrial fibrillation. (20th June 2017) - Van Der Heyden, MAG; Veldhuis, M.; Zandvoort, J.; Houtman, MJC; Duran, K.; Van Haaften, G.; Zangerl-Plessl, EM.; Takanari, H.; Stary-Weinzinger, A.; Ji, Y.